Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: It’s time to talk about aphasia
Long before Bruce Willis’ family announced his aphasia diagnosis to the world, I witnessed the effects of it firsthand through someone in my extended family. Aphasia is characterized by difficulty communicating verbally and in writing, and the most common cause of aphasia is brain damage following a stroke. The 100,000 plus Canadians who live with […]
Right Turn: CCRM hits the “airwaves” with its own podcast
Every day, it seems there is a new podcast vying for our attention. In specific terms, in 2021 there were 850,000 active podcasts with over 48 million total episodes. (Curious for more podcast stats? Check out this blog by Neal Schaffer.) Podcasts are positively proliferating in the public sphere and CCRM has parachuted onto this popular […]
Right Turn: Funding a cure
If Chip Wilson isn’t a name you recognize, I’m confident you’ve heard of Lululemon. Lululemon is the activewear company that Mr. Wilson built. Born in the U.S., but educated and living in Canada, he’s a billionaire who is using his money to find a cure for facioscapulohumeral muscular dystrophy (FSHD) – a rare disease he […]
Right Turn: Looking back on 10 amazing years at Signals
This month is the 10-year anniversary of when Lisa Willemse and I launched Signals. As you would imagine, blogs come and go so 10 years is a significant milestone. It is also my 10-year anniversary at CCRM and when I was introduced to the regenerative medicine field. In my opinion, we’ve all come a long […]